However, despite the increased specificity of the STn antibody and the number of glycoproteins with STn expressed, we were unable to demonstrate improvement over CA-125 independently or augment its ability to detect ovarian cancer except for the mucinous clear cell cancers. The gene discussed is EEF1A2; the disease is ovarian cancer.